Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy

Journal of Clinical Oncology

Volumn 22, Issue 23, 2004, Pages 4613-4621

  Huguenin, Pia ^a   Beer, Karl T ^a   Allal, Abdelkarim ^a   Rufibach, Kaspar ^a   Friedli, Corinne ^a   Davis, Jacques Bernard ^a   Pestalozzi, Bernhard ^a   Schmid, Stephan ^a   Thöni, Armin ^a   Ozsahin, Mahmut ^a   Bernier, Jacques ^a   Töpfer, Michael ^a   Kann, Roger ^a   Meier, Urs Richard ^a   Thum, Peter ^a   Bieri, Sabine ^a   Notter, Markus ^a   Lombriser, Norbert ^a   Glanzmann, Christoph ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 16544374983     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.12.193     Document Type: Article

References (25)

1. Levi F, Raymond L, Schüler G: für die Vereinigung Schweizerischer Krebsregister: Krebs in der Schweiz. Bern, Germany, Schweizerische Krebsliga, 1995
2. Fu KK, Pajak TF, Trott A, et al: A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7-16, 2000
3. Horiot JC, Le Fur R, N'Guyen TN, et al: Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25:231-240, 1992
4. Pinto LHJ, Canary PCV, Arancho CMM, et al: Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinomas. Int J Radiat Oncol Biol Phys 21:557-562, 1991
5. Pignon JP, Bouhris J, Domenge C, et al: Chemotherapy added to loco-regional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. Lancet 355:949-955, 2000
6. Browman GP, Hodson DI, Mackenzie RJ, et al: Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis. Head Neck 23:579-589, 2001
7. Lamont EB, Vockes EE: Chemotherapy in the management of squamous-cell carcinoma of the head and neck. Lancet Oncol 2:61-269, 2001
8. Vokes EE, Weichselbaum RR: Radiotherapy with concomitant chemotherapy for head and neck cancer. J Clin Oncol 8:911-934, 1990
9. Marcial VA, Pajak TF, Mohuddin M, et al: Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous-cell carcinomas of the head and neck. Cancer 66:1861-1868, 1990
10. Harrison LD, Pfister DG, Pass DE: Concomitant chemotherapy and radiation therapy for advanced unresectable head and neck cancer. Int J Radiat Oncol Biol Phys 21:703-708, 1991
11. Choi KN, Rotman M, Aziz H, et al: Locally advanced paranasal sinus and nasopharynx tumors treated with hyperfractionated radiation and concomitant infusion cisplatin. Cancer 67: 2748-2752, 1991
12. Dühmke E, Geibel T, Golms G, et al: Combined modality treatment of advanced head and neck cancer using low-dose cisplatin and accelerated fractionation. Strahlenther Onkol 164:11-16, 1988
13. Huguenin P, Glanzmann C, Taussky D, et al: Hyperfractionated radiotherapy and simultaneous cisplatin for stage-III and -IV carcinomas of the head and neck. Strahlenther Onkol 174:397-402, 1998
14. ICRU: Report 50: Prescribing, Recording and Reporting Photon Beam Therapy. Bethesda, MD. International Commission on Radiation Units and Measurements, 1993
15. Cox JD, Stetz J, Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346, 1995
16. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication 48. Geneva, Switzerland, WHO, 1979, 1985
17. Lan KKG, DeMets DL: Discrete sequential boundaries for clinical trials. Biometrika 70:659-663, 1983
18. Pampallona S, Tsiatis AA: Spending functions for the type I and type II error probabilities of group sequential tests. J Statist Plan Inference 42:19-35, 1994
19. O'Brien PC, Fleming TR: A multiple testing procedure for clinical trials. Biometrics 35:549-556, 1979
20. Thames HD, Whithers H, Peters L, et al: Changes in early and late radiation responses with altered dose per fraction: Implications for dose-survival relationships. Int J Radiat Oncol Biol Phys 8:219-226, 1982
21. Ang KK: Accelerated fractionation: What is the price for speeding? Int J Radiat Oncol Biol Phys 44:97-99, 1997
22. Jeremic B, Shibamoto Y, Milicic B, et al: Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 18:1458-1464, 2000
23. Brizel DM, Albers ME, Fisher SR, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804, 1998
24. Vokes EE, Stenson K, Rosen FR, et al: Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: Curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 21:320-326, 2003
25. Henk JM: Controlled trials of synchronous chemotherapy with radiotherapy in head and neck: Overview of radiation morbidity. Clin Oncol (R Coll Radiol) 9:308-312, 1997